Exploristics provides quantitative methods for simulating and evaluating study and development options to support key strategic decision-making for your clinical development programme.
![iStock-520095558-evidence pooling evidence pooling](https://exploristics.com/wp-content/uploads/2020/12/iStock-520095558-evidence-pooling.png)
We support decisions by pooling evidence from multiple sources
The ability to make the right decision relies on quality information. We collate and synthesise data from a range of sources such as the scientific literature, clinical trial data and real-world data sources. These sources are combined to generate a consensus view for evidence-based decision-making.
![right-development-plan Quantitative Decision-Making & Strategic Consulting](https://exploristics.com/wp-content/uploads/2021/01/right-development-plan.jpg)
We identify the right development plan by evaluating the performance of alternative development options
Development pathways can be constructed using our in-house simulation software KerusCloud. By running large numbers of study simulations, we can compare the performance of all options quickly and adjust development plans accordingly.
![QDM-3-final KerusCloud Quantitative Decision-Making & Strategic Consulting](https://exploristics.com/wp-content/uploads/2020/12/QDM-3-final.png)
We assess the impact and utility of new technologies before you make investment decisions
Clinical development is awash with new problem-solving technological solutions. We can cut through the hype by evaluating the utility of these technologies in a realistic clinical setting. With KerusCloud, we can measure the impact of new technologies in silico before any costly investment.